Mechanism of the antimineralocorticoid effects of spirolactones.
D000450:Aldosterone / Q000096:biosynthesis; D000818:Animals; D001001:Anura; D002191:Canrenoic Acid / Q000494:pharmacology; D002192:Canrenone / Q000494:pharmacology; D002417:Cattle; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D051381:Rats; D011987:Receptors, Steroid / Q000187:drug effects; D013148:Spironolactone / Q000031:analogs & derivatives / Q000494:pharmacology*; D014704:Veratrum Alkaloids / Q000494:pharmacology
D000451:Mineralocorticoid Receptor Antagonists; D011987:Receptors, Steroid; D014704:Veratrum Alkaloids; C032299:SC 8109; C002604:SC 19886; D013148:Spironolactone; C006286:SC 26304; D000450:Aldosterone; C016699:prorenone; D002192:Canrenone; D002191:Canrenoic Acid